Complass – Navigate compliance Complass – Navigate compliance

referencial

Cibersegurança para dispositivos médicos (MDR/IVDR)

Os dispositivos médicos ligados em rede e o software enquanto dispositivo médico têm de ser desenvolvidos, documentados e monitorizados no terreno de forma segura, nos termos do MDR e do IVDR. O Complass guia fabricantes e fornecedores de tecnologia médica do modelo de ameaças à notificação de vulnerabilidades.

Imagem fixa do vídeo curto «Gestão da conformidade em 20 segundos»
Gestão da conformidade em 20 segundos Projeto, próximo passo, lista de verificação, declaração de aplicabilidade, pacote de auditoria. Beispieldaten der Demo-Firma.

O que é Dispositivos médicos?

O Regulamento (UE) 2017/745 relativo aos dispositivos médicos (MDR) e o Regulamento (UE) 2017/746 relativo aos dispositivos médicos para diagnóstico in vitro (IVDR) exigem que o software seja desenvolvido de acordo com o estado da técnica, que a gestão de riscos inclua a segurança da informação e que os fabricantes definam requisitos mínimos para o hardware, as redes informáticas e as medidas de segurança informática. A orientação MDCG 2019-16 Rev. 1 explica o que isso significa na prática.

Atualidade dos conteúdos:

Aplica-se ao meu caso?

Os requisitos aplicam-se a fabricantes de dispositivos médicos e de dispositivos para diagnóstico in vitro que contêm software ou são eles próprios software. Fornecedores de eletrónica, software embebido, módulos de rádio ou fabrico por encomenda são afetados indiretamente: os fabricantes transmitem-lhes os requisitos através do sistema de gestão da qualidade e de contratos e esperam, por exemplo, SBOM, ficha técnica de segurança e compromissos de atualização.

Os dispositivos médicos estão excluídos do Cyber Resilience Act. Os componentes com elementos digitais que também são vendidos de forma autónoma ou fora da tecnologia médica ficam, em regra, abrangidos pelo CRA. Os fabricantes de dispositivos médicos e de dispositivos para diagnóstico in vitro podem, a partir de uma dimensão média, ficar adicionalmente abrangidos pela NIS2 (anexo 2 BSIG).

Esta panorâmica não substitui aconselhamento jurídico. O texto legal ou normativo é o que faz fé; no Complass, verifica a aplicabilidade com orientações baseadas nas referências.

Base jurídica

  • Art. 2 MDRArticle 2 MDR DefinitionsFor the purposes of this Regulation, the following definitions apply: (1) ‘medical device’ means any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufacturer to be used, alone or in combination, for human beings for one or more of the following specific medical purposes: - diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗Definições, entre outras de dispositivo médico e acessório
  • Art. 10 MDRArticle 10 MDR General obligations of manufacturers1. When placing their devices on the market or putting them into service, manufacturers shall ensure that they have been designed and manufactured in accordance with the requirements of this Regulation. 2. Manufacturers shall establish, document, implement and maintain a system for risk management as described in Section 3 of Annex I. 3. Manufacturers shall conduct a clinical evaluation in accordance with the …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗Obrigações gerais dos fabricantes
  • Anhang I Abschn. 17.2 MDRAnnex I Section 17.2 MDRFor devices that incorporate software or for software that are devices in themselves, the software shall be developed and manufactured in accordance with the state of the art taking into account the principles of development life cycle, risk management, including information security, verification and validation.Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗Ciclo de vida do software, gestão de riscos incluindo a segurança da informação
  • Anhang I Abschn. 17.4 MDRAnnex I Section 17.4 MDRManufacturers shall set out minimum requirements concerning hardware, IT networks characteristics and IT security measures, including protection against unauthorised access, necessary to run the software as intended.Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗Requisitos mínimos para hardware, redes informáticas e medidas de segurança informática
  • Art. 83 MDRArticle 83 MDR Post-market surveillance system of the manufacturer1. For each device, manufacturers shall plan, establish, document, implement, maintain and update a post-market surveillance system in a manner that is proportionate to the risk class and appropriate for the type of device. That system shall be an integral part of the manufacturer's quality management system referred to in Article 10(9). 2. The post-market surveillance system shall be suited to actively and …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗Sistema de vigilância pós-comercialização
  • Art. 87 MDRArticle 87 MDR Reporting of serious incidents and field safety corrective actions1. Manufacturers of devices made available on the Union market, other than investigational devices, shall report, to the relevant competent authorities, in accordance with Articles 92(5) and (7), the following: - (a) any serious incident involving devices made available on the Union market, except expected side-effects which are clearly documented in the product information and quantified in the technical …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗Notificação de incidentes graves e ações corretivas de segurança no terreno
  • Anhang I Abschn. 16.2 IVDRAnnex I Section 16.2 IVDRFor devices that incorporate software or for software that are devices in themselves, the software shall be developed and manufactured in accordance with the state of the art taking into account the principles of development life cycle, risk management, including information security, verification and validation.Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Abrir o original (EUR-Lex – consolidated version of 10.01.2025) ↗Requisito correspondente para software de dispositivos para diagnóstico in vitro
  • Art. 2 Abs. 2 CRAArtigo 2 Regulamento de Ciber-Resiliência Âmbito de aplicação1. O presente regulamento é aplicável aos produtos com elementos digitais disponibilizados no mercado cuja finalidade prevista ou utilização razoavelmente previsível inclua uma conexão de dados lógica ou física, direta ou indireta, a um dispositivo ou a uma rede. 2. O presente regulamento não é aplicável aos produtos com elementos digitais aos quais sejam aplicáveis os seguintes atos jurídicos da União: - a) …Versão de: 06.10.2026 · Fonte: EUR-Lex – OJ L 2024/2847, 20.11.2024, corrigenda incorporated: OJ L 2025/90555, 2.7.2025; OJ L 2025/90828, 17.10.2025Abrir o original (EUR-Lex – OJ L 2024/2847, 20.11.2024, corrigenda incorporated: OJ L 2025/90555, 2.7.2025; OJ L 2025/90828, 17.10.2025) ↗Exclusão dos dispositivos médicos do Cyber Resilience Act

Datas-chave

  1. Date of application of the MDR · Art. 123(2) MDRArticle 123 MDR Entry into force and date of application1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2. It shall apply from 26 May 2021 . 3. By way of derogation from paragraph 2: - (a) Articles 35 to 50 shall apply from 26 November 2017. However, from that date until 26 May 2021 , the obligations on notified bodies pursuant to Articles 35 to 50 shall apply only to those …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗
  2. Date of application of the IVDR · Art. 113(2) IVDRArticle 113 IVDR Entry into force and date of application1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2. It shall apply from 26 May 2022. 3. By way of derogation from paragraph 2: ————— - (b) Articles 31 to 46 and Article 96 shall apply from 26 November 2017. However, from that date until 26 May 2022 the obligations on notified bodies pursuant to Articles 31 to 46 shall …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Abrir o original (EUR-Lex – consolidated version of 10.01.2025) ↗
  3. MDR legacy devices: QMS in accordance with Art. 10(9) put in place and formal application lodged with a notified body (condition of the transitional period) · Art. 120(3c)(d) and (e) MDRArticle 120 MDR Transitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗
  4. MDR legacy devices: written agreement signed with the notified body (condition of the transitional period) · Art. 120(3c)(e) MDRArticle 120 MDR Transitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗
  5. Obligations relating to the first Eudamed modules (actors, UDI/devices, notified bodies and certificates, market surveillance) apply · Art. 123(3)(d) MDR in conjunction with Decision (EU) 2025/2371Article 123 MDR Entry into force and date of application1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2. It shall apply from 26 May 2021 . 3. By way of derogation from paragraph 2: - (a) Articles 35 to 50 shall apply from 26 November 2017. However, from that date until 26 May 2021 , the obligations on notified bodies pursuant to Articles 35 to 50 shall apply only to those …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗
  6. IVDR legacy devices of class B and sterile class A: formal application lodged with a notified body no later than · Art. 110(3c)(e)(iii) IVDRArticle 110 IVDR Transitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Abrir o original (EUR-Lex – consolidated version of 10.01.2025) ↗
  7. IVDR legacy devices of class B and sterile class A: written agreement with the notified body no later than · Art. 110(3c)(f)(iii) IVDRArticle 110 IVDR Transitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Abrir o original (EUR-Lex – consolidated version of 10.01.2025) ↗
  8. End of the MDR transitional period for class III and class IIb implantable devices (with exceptions), under the conditions of Art. 120(3c) · Art. 120(3a)(a) MDRArticle 120 MDR Transitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗
  9. End of the IVDR transitional period for devices with a certificate under Directive 98/79/EC and for class D, under the conditions of Art. 110(3c) · Art. 110(3a), (3b)(a) IVDRArticle 110 IVDR Transitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Abrir o original (EUR-Lex – consolidated version of 10.01.2025) ↗
  10. End of the MDR transitional period for other class IIb, class IIa, class I sterile or with a measuring function, and for devices that require a notified body only under the MDR · Art. 120(3a)(b), (3b) MDRArticle 120 MDR Transitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Abrir o original (EUR-Lex – consolidated version of 19.07.2026) ↗
  11. End of the IVDR transitional period for class C · Art. 110(3b)(b) IVDRArticle 110 IVDR Transitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Abrir o original (EUR-Lex – consolidated version of 10.01.2025) ↗
  12. End of the IVDR transitional period for class B and sterile class A · Art. 110(3b)(c) IVDRArticle 110 IVDR Transitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Versão de: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Abrir o original (EUR-Lex – consolidated version of 10.01.2025) ↗

Início de aplicação e prazos transitórios segundo as versões consolidadas do MDR e do IVDR. Uma proposta da Comissão de 16.12.2025 (COM(2025) 1023) prevê obrigações de notificação adicionais para vulnerabilidades; ainda não foi aprovada.

Como o Complass ajuda

  • Sete fases ao longo do ciclo de vida

    Classificação e função, desenvolvimento seguro com gestão de riscos, requisitos mínimos para o ambiente informático, documentação técnica, vigilância pós-comercialização e vigilância, bem como uma fase própria para fornecedores.

  • Catálogos de requisitos

    Requisitos de cibersegurança do MDR e do IVDR, medidas segundo a MDCG 2019-16 e atividades de segurança no ciclo de vida com estado e evidência, interligáveis com CRA, IEC 62443 e ISO 27001.

  • Modelos

    entre outros: plano de segurança, modelo de ameaças, dossiê de gestão de riscos de segurança, registo de SBOM, requisitos mínimos para o ambiente informático, política de divulgação coordenada, conceito de patches e atualizações e acordo de segurança com fornecedores.

  • Vulnerabilidades e incidentes

    Comparação da SBOM com vulnerabilidades conhecidas, registo de incidentes e visão geral dos prazos de notificação.

As fases no módulo

  1. Qualification, role and demarcation
  2. Secure development across the lifecycle
  3. Minimum requirements for the IT environment and operator information
  4. Technical documentation and conformity assessment
  5. After placing on the market: surveillance, vulnerabilities, updates and vigilance
  6. Suppliers to the medical technology industry
  7. Implementation in Complass

Catálogo: MDR/IVDR requirements relevant to cybersecurity

Módulos adequados

Ofertas adequadas

O modelo setorial «Tecnologia médica» pré-seleciona o referencial para o MDR e o IVDR e os módulos de que precisa para o modelo de ameaças, as vulnerabilidades e os fornecedores.

disponível

Modelo setorial: Tecnologia médica

  • Cibersegurança para dispositivos médicos segundo o MDR e o IVDR
  • Vulnerabilidades e SBOM
  • Gestão de riscos
  • MITRE ATT&CK para o modelo de ameaças
  • Supplier Management

a partir de 476 € por mês mais IVA no pacote Start, tamanho S, pagamento anual

Todos os preços destinam-se a empresas, não a consumidores. Entendem-se líquidos mais IVA com pagamento anual; com pagamento mensal aplica-se um acréscimo de 15 %. Atualizado em 16/10/2026. Enterprise e grupos empresariais sob consulta.

Perguntas frequentes

Fornecemos apenas eletrónica e firmware a fabricantes de tecnologia médica. Isto aplica-se a nós?

Indiretamente, sim: os seus clientes têm de comprovar os requisitos de cibersegurança do MDR e esperam de si informações e compromissos para isso. Se vender o componente também a outros setores, aplica-se em regra adicionalmente o Cyber Resilience Act. O módulo contém uma fase própria para fornecedores.

O módulo substitui o nosso sistema de gestão da qualidade?

Não. O Complass estrutura os requisitos de cibersegurança e as evidências e pode ser integrado no seu SGQ existente; a avaliação da conformidade e as aprovações permanecem consigo e com o seu organismo notificado.

Estão incluídas normas como a IEC 81001-5-1?

O módulo descreve as atividades por palavras próprias, com referência às secções. O texto da norma obtém-no através do comércio de normas; pode guardar no projeto excertos da sua edição licenciada.

Teste o Complass com os seus próprios dados

Crie o seu próprio acesso de teste, se quiser com um projeto de exemplo por referencial. Se preferir ver primeiro o Complass, peça uma demonstração.